newsfilter
← Latest News
PR Newswire·

Fusion Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference

HAMILTON, ON and BOSTON, April 20, 2023 /CNW/ -- Fusion Pharmaceuticals Inc. (NASDAQ:FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today